Sheba Medical Center at Tel Hashomer, and Lonza have entered a collaboration to develop point-of-care cell-therapy manufacturing using the Cocoon manufacturing platform. The partnership will enable Sheba to streamline its in-house cell manufacturing process and produce genetically engineered human CAR-T cells for applications in treating critically ill oncology patients.   This collaborative agreement brings together a leading academic clinical center and an established development and manufac...